Teton Advisors’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
TCM
Teton Advisors's ANGO Position: Q2 2019 in Review
Teton Advisors sold out of AngioDynamics (ANGO) in Q2 2019, closing a stake of 18,000 shares — an estimated $411K sold.
Teton Advisors first reported a position in ANGO in Q2 2013 and held it in 24 quarters. The position peaked at $1.49M in Q4 2013. 167 funds tracked by Wall St. Rank hold ANGO as of Q2 2019.
- Teton Advisors reported no remaining AngioDynamics position as of Q2 2019 after selling out during the quarter.
- Teton Advisors sold 18,000 AngioDynamics shares in Q2 2019, an estimated $411K.
- Teton Advisors first reported a position in AngioDynamics in Q2 2013 and held it in 24 quarters.
- Teton Advisors's AngioDynamics position peaked at $1.49M in Q4 2013.
- 167 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2019.
Based on Teton Advisors's 13F filing for Q2 2019, filed 2 Aug 2019.